Osmotic pump type controlled release preparation of kurarinone and its preparing method

A technology for controlled release preparations and matrine, which is applied in pharmaceutical formulations, antiviral agents, medical preparations containing active ingredients, etc., and can solve problems that are difficult to industrialize large-scale production, difficult to control the release rate, and product batch-to-batch differences. It can reduce toxic and side effects, facilitate administration and administration, and maintain a long time.

Inactive Publication Date: 2004-03-10
SHENYANG PHARMA UNIVERSITY
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Matrine has excellent water solubility, and it is not easy to control the drug release rate. The main difficulty is to control the stable release of the

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Osmotic pump type controlled release preparation of kurarinone and its preparing method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Tablet Prescription:

[0031] Matrine 300.0g

[0032] Sodium chloride 200.0g

[0033] Lactose 77.0g

[0034] Magnesium Stearate 3g

[0035] Preparation of tablet cores: crush the prescribed amount of medicine, sodium chloride and lactose, sieve, mix evenly, use 95% ethanol as a wetting agent to make a soft material, granulate with a 20-mesh sieve, and dry the wet granules at 50±5°C. Sieve with 18 meshes, mix the dry granules with a lubricant, and press into tablets to obtain 1000 tablet cores.

[0036] Coating Solution Prescription:

[0037] Cellulose acetate 100g

[0038] PEG6000 12g

[0039] Dibutyl phthalate 13mL

[0040] Acetone 5L

[0041]Coating process: put the tablet core in the coating pan, blow in hot air, and coat the tablet core when the temperature is about 40°C. The flow rate of the coating solution is 5-10mL / min, and the pressure is 0.8kg / cm2 ,...

Embodiment 2

[0043] Tablet Prescription:

[0044] Matrine 300.0g

[0045] Sucrose 100.0g

[0046] Lactose 177.0g

[0047] Magnesium Stearate 3g

[0048] Tablet core preparation, with embodiment 1:

[0049] Coating Solution Prescription:

[0050] Cellulose acetate 100g

[0051] PEG6000 12g

[0052] Dibutyl phthalate 5mL

[0053] Acetone 5L

[0054] Coating process, with embodiment 1.

Embodiment 3

[0056] Tablet Prescription:

[0057] Matrine 300.0g

[0058] Sodium chloride 200.0g

[0059] Pregelatinized starch 77.0g

[0060] Magnesium Stearate 3g

[0061] Tablet core preparation: same as in Example 1.

[0062] Coating liquid prescription: with embodiment 1.

[0063] Coating process: with embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A release controlled osmotic pump type kurarinol is prepared from kurarinol, diluent, osmosis promoter, lubricant and adhesive through pulverizing, sieving, mixing, adding alcohol, granulating, drying, adding lubricant, talbetting, and coating. Its advantages are long time for maintaining effective blood concentration, and less peak and valley of blood concentration.

Description

Technical field: [0001] The invention relates to a new pharmaceutical dosage form of matrine, specifically, it is a osmotic pump type controlled release preparation of matrine and a preparation method thereof. Background technique: [0002] Matrine is an active ingredient extracted from the traditional Chinese medicine Sophora alopecuroides L or Sophora flavescens Ait, and the content of oxymatrine (Oxymatrine) is more than 98%. Pharmacological and clinical studies have shown that it has anti-tumor , antibacterial, antiviral, improve liver function and prevent liver fibrosis, reduce transaminase, improve the body's immunity and so on. At present, matrine has been identified as a key promotional engineering drug for the treatment of viral hepatitis. It can significantly inhibit the infection of hepatitis B virus. According to quantitative gene detection, after using matrine, the replication level of hepatitis B virus in infected cells is significantly reduced, which shows tha...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/22A61K31/4375A61P1/16A61P31/04A61P31/12A61P35/00
Inventor 何仲贵唐景玲
Owner SHENYANG PHARMA UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap